Lv2
130 积分 2025-05-30 加入
Efficacy and safety of gemcitabine/nab-paclitaxel combined with anlotinib and PD-1 inhibitors as a first-line treatment for advanced pancreatic cancer
5天前
已完结
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
1个月前
已完结
Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective
2个月前
已完结
N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions
2个月前
已关闭
Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration
2个月前
已完结
Metabolism of new drug modalities research advances – 2024 year in review
2个月前
已完结
Drug Targeting Towards the Lymphatics
2个月前
已完结
Drug Targeting Towards the Lymphatics
2个月前
已关闭
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
3个月前
已完结
Taming the Beast: How to Optimize DMPK–PD Properties of Oral Degraders
3个月前
已完结
皖公网安备34019202002308
